{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:12:34Z","timestamp":1760983954136},"reference-count":12,"publisher":"Cambridge University Press (CUP)","issue":"5","license":[{"start":{"date-parts":[[2011,1,31]],"date-time":"2011-01-31T00:00:00Z","timestamp":1296432000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Laryngol. Otol."],"published-print":{"date-parts":[[2011,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S002221511000304X_sec1\"><jats:title>Objective:<\/jats:title><jats:p>To report the results of transoral laser microsurgery for the treatment of early glottic cancer at our institution.<\/jats:p><\/jats:sec><jats:sec id=\"S002221511000304X_sec2\"><jats:title>Design:<\/jats:title><jats:p>Cohort study. Retrospective review of charts of patients diagnosed with tumour stage 1 or 2 (early stage; no nodes or metastases), previously untreated, primary glottic cancer, treated with transoral laser microsurgery at the Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada. The minimum follow-up period was two years.<\/jats:p><\/jats:sec><jats:sec id=\"S002221511000304X_sec3\"><jats:title>Setting:<\/jats:title><jats:p>Tertiary care head and neck cancer centre.<\/jats:p><\/jats:sec><jats:sec id=\"S002221511000304X_sec4\"><jats:title>Participants:<\/jats:title><jats:p>Fifty-three patients treated between January 2002 and November 2007.<\/jats:p><\/jats:sec><jats:sec id=\"S002221511000304X_sec5\"><jats:title>Outcome measure:<\/jats:title><jats:p>Kaplan\u2013Meier survival analysis for disease-free survival, overall survival and laryngectomy-free survival, at five years.<\/jats:p><\/jats:sec><jats:sec id=\"S002221511000304X_sec6\"><jats:title>Results:<\/jats:title><jats:p>The group comprised 46 men and seven women, with a mean age of 66 years (range 30\u201384 years). Mean follow up was 40 months (range 12\u201389 months). There were four cases of complications (7.5 per cent). Kaplan\u2013Meier survival analysis revealed a five-year disease-free survival (including salvage) of 96.2 per cent, a five-year overall survival (all causes) of 88.8 per cent and a five-year laryngectomy-free survival of 98.1 per cent.<\/jats:p><\/jats:sec><jats:sec id=\"S002221511000304X_sec7\"><jats:title>Conclusion:<\/jats:title><jats:p>Transoral laser microsurgery is a safe and effective initial treatment for early laryngeal cancer, and has high rates of laryngeal preservation and disease-free survival.<\/jats:p><\/jats:sec>","DOI":"10.1017\/s002221511000304x","type":"journal-article","created":{"date-parts":[[2011,1,31]],"date-time":"2011-01-31T08:36:58Z","timestamp":1296463018000},"page":"509-512","source":"Crossref","is-referenced-by-count":15,"title":["Transoral laser microsurgery outcomes with early glottic cancer: the Dalhousie University experience"],"prefix":"10.1017","volume":"125","author":[{"given":"S E","family":"Lester","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M H","family":"Rigby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S M","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2011,1,31]]},"reference":[{"key":"S002221511000304X_ref12","doi-asserted-by":"publisher","DOI":"10.1177\/000348940611500803"},{"key":"S002221511000304X_ref11","first-page":"582","article-title":"Endoscopic treatment of Cis-T2 glottic cancer with a CO2 laser: 2-year survival analysis of 36 cases","volume":"37","author":"Taylor","year":"2008","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"S002221511000304X_ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-009-1028-2"},{"key":"S002221511000304X_ref9","first-page":"434","article-title":"Radiotherapy for T1 and T2 laryngeal cancer: the Dalhousie University experience","volume":"38","author":"Hafidh","year":"2009","journal-title":"Otolaryngol Head Neck Surg"},{"key":"S002221511000304X_ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2007.06.008"},{"key":"S002221511000304X_ref6","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20181"},{"key":"S002221511000304X_ref8","doi-asserted-by":"publisher","DOI":"10.1002\/hed.21027"},{"key":"S002221511000304X_ref4","doi-asserted-by":"publisher","DOI":"10.1002\/hed.20852"},{"key":"S002221511000304X_ref2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.4559"},{"key":"S002221511000304X_ref3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002027"},{"key":"S002221511000304X_ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-4486.2009.01944.x"},{"key":"S002221511000304X_ref5","doi-asserted-by":"publisher","DOI":"10.1001\/archoto.2009.47"}],"container-title":["The Journal of Laryngology &amp; Otology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S002221511000304X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T04:51:00Z","timestamp":1556340660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S002221511000304X\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,31]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S002221511000304X"],"URL":"https:\/\/doi.org\/10.1017\/s002221511000304x","relation":{},"ISSN":["0022-2151","1748-5460"],"issn-type":[{"value":"0022-2151","type":"print"},{"value":"1748-5460","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,31]]}}}